Home » Case Studies » Value Access and Pricing » Local Launch Strategy in Russi…

Local Launch Strategy in Russia

CBPartners engaged with local Russian stakeholders to assess how PRODUCT X’s value in ABSSSI translates into market access scenarios and pricing opportunity.


To develop a strong supporting body of evidence communicating local stakeholder perceptions of PRODUCT X’s value and expected pricing and market access in acute bacterial skin and skin structure infections (ABSSSI).



Perform secondary research to identify key stakeholders for uptake within an acute hospital setting and map the local RUS landscape for PRODUCT X access / funding; conduct a primary research follow-up with ANO NC HTA authorities / advisors, hospital advisors, and key opinion leaders (KOLs) to define local perceptions, risks and opportunities for PRODUCT X.


  • Funding flow map and stakeholder mapping
  • Local market access scenarios for PRODUCT X
  • PRODUCT X pricing opportunity and risk assessment
  • Value positioning and stakeholder impact assessment
  • Final recommendations & executive summary

Illustrative Outputs


CBPartners provided key insights to inform the PRODUCT X local launch strategy in RUS, including expected coverage and pricing recommendations.